Aarti Drugs Limited

Stocks

Market Closed - Bombay S.E. Other stock markets 11:00:51 14/07/2026 BST			5-day change	1st Jan Change
406.80 ^INR	+2.96%		+4.75%	-1.23%

05-18	Aarti Drugs Limited, Q4 2026 Earnings Call, May 18, 2026
05-15	Aarti Drugs Limited Announces Reconstitution of Risk Committee, Effective May 15, 2026	CI

Published on 07/21/2025 at 08:05 am BST - Modified on 07/21/2025 at 11:35 am BST

S&P Capital IQ

Presentation Operator Message
Operator (Operator)

Ladies and gentlemen, good day, and welcome to the Aarti Drugs Limited Q1 FY '26 Earnings Conference Call. [Operator Instructions] Please note that

This article is reserved for subscribers

Unlock the article : SUBSCRIBE!

Already a customer? Log In

05-18	Aarti Drugs Limited, Q4 2026 Earnings Call, May 18, 2026
05-15	Aarti Drugs Limited Announces Reconstitution of Risk Committee, Effective May 15, 2026	CI
05-15	Aarti Drugs March-quarter consol profit 552.6 million rupees	RE
05-15	Aarti Drugs Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026	CI
03-06	Pinnacle Life Science Pvt. Ltd announced that it expects to receive INR 100 million in funding from Aarti Drugs Limited	CI
02-04	Aarti Drugs Limited, Q3 2026 Earnings Call, Feb 04, 2026
02-03	Aarti Drugs dividend 2 rupees per share	RE
02-03	Aarti Drugs Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025	CI
02-03	Aarti Drugs Dec-quarter Consol Net Profit 405.4 Million Rupees	RE
02-03	Aarti Drugs Limited Declares Interim Dividend for the Financial Year 2025-26	CI
11-10	Aarti Drugs Limited, Q2 2026 Earnings Call, Nov 10, 2025
11-07	Aarti Drugs Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025	CI
05/09/25	Aarti Drugs Sayakha Plant Commences Commercial Production	MT
04/09/25	Aarti Drugs commences commercialization of manufacturing plant located at Sayakha	RE
21/07/25	Aarti Drugs Limited, Q1 2026 Earnings Call, Jul 21, 2025